Pirfenidone | Horizonscan geneesmiddelen

Posted by: admin Categories: Idiopathic Pulmonary Fibrosis

Pirfenidone | Horizonscan geneesmiddelen

www.horizonscan.nl gebruikt cookies om het gebruik van de website te analyseren en het gebruiksgemak te verbeteren. Lees meer over cookies op www.rijkshuisstijl.nl

Extended indication	Extension of indication to include the treatment of unclassifiable interstitial lung disease (UILD) for Esbrie.
Therapeutic value	No estimate possible yet
Registration phase	No registration expected

Table of Contents

Product

Active substance	Pirfenidone
Domain	Lung diseases
Reason of inclusion	Indication extension
Main indication	Lung diseases other
Extended indication	Extension of indication to include the treatment of unclassifiable interstitial lung disease (UILD) for Esbrie.
Proprietary name	Esbriet
Manufacturer	Roche
Mechanism of action	Other, see general comments
Route of administration	Oral
Therapeutical formulation	Tablet
Budgetting framework	Intermural (MSZ)

Registration

Registration route	Centralised (EMA)
Submission date	January 2021
Orphan drug	Yes
Registration phase	No registration expected

Therapeutic value

Therapeutic value	No estimate possible yet

Expected patient volume per year

There is currently nothing known about the expected patient volume.

Expected cost per patient per year

There is currently nothing known about the expected cost.

Potential total cost per year

There is currently nothing known about the possible total cost.

Off label use

There is currently nothing known about off label use.

Indication extension

There is currently nothing known about indication extensions.

Other information

There is currently no futher information available.

« Generic 50x70cm Modern A Watercolor Green Plant Canvas Palm Leaf Wal

Red Wings place 5 in COVID protocol including coach Jeff Blashill »

Latest Tweets

Breathing+ by Breathing Labs has passed peer review in a randomized controlled clinical trial that was recently pub… twitter.com/i/web/status/15431…
July 2, 2022 11:37 am
BREAKING: @breathinglabs and @Nintendo clinical trial is published in journal Pediatric Pulmonology (SCI Q2, Impact… twitter.com/i/web/status/15404…
June 24, 2022 10:20 pm
Clinical mouthpieces 10pcs packages are now available at 45€/50USD (shipping cost not included). Learn more:… twitter.com/i/web/status/15000…
March 5, 2022 10:56 am
BREATHING VR: Lately we are sourcing this VR headset for use in Breathing VR application. It allows easiest install… twitter.com/i/web/status/13990…
May 30, 2021 3:52 pm
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be su… twitter.com/i/web/status/13328…
November 28, 2020 10:41 pm
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that… twitter.com/i/web/status/13237…
November 3, 2020 7:31 pm
Registration and all functionalities at breathinglabs.com (and in our iOS and Android games) are fixed and fu… twitter.com/i/web/status/12407…
March 19, 2020 10:50 pm
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys… twitter.com/i/web/status/11717…
September 11, 2019 12:00 pm
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial… twitter.com/i/web/status/11580…
August 4, 2019 5:55 pm